Kymera Therapeutics, Inc. (KYMR)
75.07
+1.12
(+1.51%)
USD |
NASDAQ |
Jun 09, 14:22
Kymera Therapeutics EPS Diluted (TTM) : -3.571 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Revolution Medicines, Inc. | -7.073 |
| Erasca, Inc. | -0.9328 |
| Arrowhead Pharmaceuticals, Inc. | -2.148 |
| Sarepta Therapeutics, Inc. | -0.9641 |
| Vir Biotechnology, Inc. | -3.137 |